
Biologics CDMO Global Market Report 2025
Description
Biologics CDMO Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on biologics cdmo market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for biologics cdmo ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biologics cdmo market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Cell Type: Mammalian; Non-Mammalian
2) By Product Type: Biologics; Biosimilars
Subsegments:
1) By Mammalian: Chinese Hamster Ovary (CHO) Cells; Human Embryonic Kidney (HEK) Cells; Other Mammalian Cells
2) By Non-Mammalian: Yeast Cells; Bacterial Cells; Insect Cells; Other Non-Mammalian Cells
Companies Mentioned: AbbVie Inc.; Thermo Fisher Scientific Inc.; Novartis AG; Evonik Industries AG; Sandoz International GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
This report focuses on biologics cdmo market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for biologics cdmo ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biologics cdmo market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Cell Type: Mammalian; Non-Mammalian
2) By Product Type: Biologics; Biosimilars
Subsegments:
1) By Mammalian: Chinese Hamster Ovary (CHO) Cells; Human Embryonic Kidney (HEK) Cells; Other Mammalian Cells
2) By Non-Mammalian: Yeast Cells; Bacterial Cells; Insect Cells; Other Non-Mammalian Cells
Companies Mentioned: AbbVie Inc.; Thermo Fisher Scientific Inc.; Novartis AG; Evonik Industries AG; Sandoz International GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
200 Pages
- 1. Executive Summary
- 2. Biologics CDMO Market Characteristics
- 3. Biologics CDMO Market Trends And Strategies
- 4. Biologics CDMO Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
- 5. Global Biologics CDMO Growth Analysis And Strategic Analysis Framework
- 5.1. Global Biologics CDMO PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Biologics CDMO Market Growth Rate Analysis
- 5.4. Global Biologics CDMO Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Biologics CDMO Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Biologics CDMO Total Addressable Market (TAM)
- 6. Biologics CDMO Market Segmentation
- 6.1. Global Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Mammalian
- Non-Mammalian
- 6.2. Global Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Biologics
- Biosimilars
- 6.3. Global Biologics CDMO Market, Sub-Segmentation Of Mammalian, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Chinese Hamster Ovary (CHO) Cells
- Human Embryonic Kidney (HEK) Cells
- Other Mammalian Cells
- 6.4. Global Biologics CDMO Market, Sub-Segmentation Of Non-Mammalian, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Yeast Cells
- Bacterial Cells
- Insect Cells
- Other Non-Mammalian Cells
- 7. Biologics CDMO Market Regional And Country Analysis
- 7.1. Global Biologics CDMO Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Biologics CDMO Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Biologics CDMO Market
- 8.1. Asia-Pacific Biologics CDMO Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Biologics CDMO Market
- 9.1. China Biologics CDMO Market Overview
- 9.2. China Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Biologics CDMO Market
- 10.1. India Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Biologics CDMO Market
- 11.1. Japan Biologics CDMO Market Overview
- 11.2. Japan Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Biologics CDMO Market
- 12.1. Australia Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Biologics CDMO Market
- 13.1. Indonesia Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Biologics CDMO Market
- 14.1. South Korea Biologics CDMO Market Overview
- 14.2. South Korea Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Biologics CDMO Market
- 15.1. Western Europe Biologics CDMO Market Overview
- 15.2. Western Europe Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Biologics CDMO Market
- 16.1. UK Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Biologics CDMO Market
- 17.1. Germany Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Biologics CDMO Market
- 18.1. France Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Biologics CDMO Market
- 19.1. Italy Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Biologics CDMO Market
- 20.1. Spain Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Biologics CDMO Market
- 21.1. Eastern Europe Biologics CDMO Market Overview
- 21.2. Eastern Europe Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Biologics CDMO Market
- 22.1. Russia Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Biologics CDMO Market
- 23.1. North America Biologics CDMO Market Overview
- 23.2. North America Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Biologics CDMO Market
- 24.1. USA Biologics CDMO Market Overview
- 24.2. USA Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Biologics CDMO Market
- 25.1. Canada Biologics CDMO Market Overview
- 25.2. Canada Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Biologics CDMO Market
- 26.1. South America Biologics CDMO Market Overview
- 26.2. South America Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Biologics CDMO Market
- 27.1. Brazil Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Biologics CDMO Market
- 28.1. Middle East Biologics CDMO Market Overview
- 28.2. Middle East Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Biologics CDMO Market
- 29.1. Africa Biologics CDMO Market Overview
- 29.2. Africa Biologics CDMO Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Biologics CDMO Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Biologics CDMO Market Competitive Landscape And Company Profiles
- 30.1. Biologics CDMO Market Competitive Landscape
- 30.2. Biologics CDMO Market Company Profiles
- 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sandoz International GmbH Overview, Products and Services, Strategy and Financial Analysis
- 31. Biologics CDMO Market Other Major And Innovative Companies
- 31.1. ICON PLC
- 31.2. Grifols SA
- 31.3. Lonza Group Ltd.
- 31.4. Boehringer Ingelheim International GmbH
- 31.5. Catalent Inc.
- 31.6. JSR Corp.
- 31.7. Parexel International Corporation
- 31.8. WuXi Biologics (Cayman) Inc.
- 31.9. Samsung Biologics Co. Ltd.
- 31.10. Emergent BioSolutions Inc.
- 31.11. Rentschler Biopharma SE
- 31.12. FUJIFILM Diosynth Biotechnologies U.S.A. Inc.
- 31.13. Binex Co. Ltd.
- 31.14. Bora Pharmaceuticals Co. Ltd
- 31.15. 3P Biopharmaceuticals s.l.u
- 32. Global Biologics CDMO Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Biologics CDMO Market
- 34. Recent Developments In The Biologics CDMO Market
- 35. Biologics CDMO Market High Potential Countries, Segments and Strategies
- 35.1 Biologics CDMO Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Biologics CDMO Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Biologics CDMO Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.